Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea L Kwa

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Expert Review of Anti-Infective Therapy|October 22, 2015
Polymyxin B versus colistin: an updateYiying Cai, Winnie Lee, Andrea L Kwa
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2011
Dual pneumococcal and influenza vaccination in elderly patients with chronic illnesses: protective benefits overestimated?Rachel Ong, Andrea L Kwa, Winnie Lee
International Journal of Antimicrobial Agents|November 27, 2015
Intravenous ceftaroline 200 mg administered every 8 h is safe and adequate for meticillin-resistant Staphylococcus aureus bloodstream infections in end-stage renal failure patients on haemodialysis: a case studyShimin J Chung, Tze-Peng Lim, Andrea L Kwa
Annals of the Academy of Medicine, Singapore|November 28, 2008
Polymyxins: a review of the current status including recent developmentsAndrea L Kwa, Vincent H Tam, Matthew E Falagas
Jac-Antimicrobial Resistance|August 5, 2022
Identification and genomic characterization of a <i>bla</i> <sub>NDM-5</sub>-harbouring MDR plasmid in a carbapenem-resistant <i>Escherichia coli</i> ST410 strain isolated from a natural water environmental sourceYang Zhong, Siyao Guo, Joergen Schlundt, et al.
The Journal of Antimicrobial Chemotherapy|November 22, 2008
Comment on: Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasmaVincent H Tam, Jingguo Hou, Andrea L Kwa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Benefits of aerosolized colistin for ventilator-associated pneumonia: absence of proof versus proof of absence?Andrea L Kwa, Matthew E Falagas, Argyris Michalopoulos, et al.
Microbiology Spectrum|November 1, 2023
First report of environmental <i>bla</i> <sub>PAC-1</sub>-carrying <i>Aeromonas enteropelogenes</i>Yang Zhong, Siyao Guo, Shuhua Thong, et al.
Scandinavian Journal of Infectious Diseases|August 15, 2014
Echinocandin-induced eosinophilia: a case reportNathalie G Chua, Yvonne P Zhou, Pushpalatha B Lingegowda, et al.
International Journal of Antimicrobial Agents|May 25, 2026
The costs and health outcomes associated with a personalised antibiotic combination testing service for carbapenem-resistant Pseudomonas aeruginosa: a cost-effectiveness analysisYiying Cai, Tze-Peng Lim, Winnie Lee, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Expert Review of Anti-Infective Therapy|October 22, 2015
Polymyxin B versus colistin: an updateYiying Cai, Winnie Lee, Andrea L Kwa
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2011
Dual pneumococcal and influenza vaccination in elderly patients with chronic illnesses: protective benefits overestimated?Rachel Ong, Andrea L Kwa, Winnie Lee
International Journal of Antimicrobial Agents|November 27, 2015
Intravenous ceftaroline 200 mg administered every 8 h is safe and adequate for meticillin-resistant Staphylococcus aureus bloodstream infections in end-stage renal failure patients on haemodialysis: a case studyShimin J Chung, Tze-Peng Lim, Andrea L Kwa
Annals of the Academy of Medicine, Singapore|November 28, 2008
Polymyxins: a review of the current status including recent developmentsAndrea L Kwa, Vincent H Tam, Matthew E Falagas
Jac-Antimicrobial Resistance|August 5, 2022
Identification and genomic characterization of a <i>bla</i> <sub>NDM-5</sub>-harbouring MDR plasmid in a carbapenem-resistant <i>Escherichia coli</i> ST410 strain isolated from a natural water environmental sourceYang Zhong, Siyao Guo, Joergen Schlundt, et al.
The Journal of Antimicrobial Chemotherapy|November 22, 2008
Comment on: Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasmaVincent H Tam, Jingguo Hou, Andrea L Kwa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Benefits of aerosolized colistin for ventilator-associated pneumonia: absence of proof versus proof of absence?Andrea L Kwa, Matthew E Falagas, Argyris Michalopoulos, et al.
Microbiology Spectrum|November 1, 2023
First report of environmental <i>bla</i> <sub>PAC-1</sub>-carrying <i>Aeromonas enteropelogenes</i>Yang Zhong, Siyao Guo, Shuhua Thong, et al.
Scandinavian Journal of Infectious Diseases|August 15, 2014
Echinocandin-induced eosinophilia: a case reportNathalie G Chua, Yvonne P Zhou, Pushpalatha B Lingegowda, et al.
International Journal of Antimicrobial Agents|May 25, 2026
The costs and health outcomes associated with a personalised antibiotic combination testing service for carbapenem-resistant Pseudomonas aeruginosa: a cost-effectiveness analysisYiying Cai, Tze-Peng Lim, Winnie Lee, et al.
Pageof 5